Xellia

Denmark Updated 9 July 2026

The public registers hold a second record for Xellia. The fuller profile, with 19 active US DMFs and 0 valid CEPs, is at Xellia Pharmaceuticals. Figures on this page cover only this record.

Xellia is an API manufacturer based in Denmark. It appears in 3 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with ANSM (FR) and ANPP (DZ).

active US DMFs

valid CEPs

registered plants

filings across 2 regulators

What they file, and where

Molecule	Regulators	Docs
Vancomycin	SFDA (Saudi Arabia)	1

Also appears on these molecule pages

Vancomycin API

Filings and GMP by regulator

Regulator	Filings	GMP certificates
ANSM (FR)	2	None
ANPP (DZ)	1	None

Questions about Xellia

Does Xellia hold a US DMF or a CEP?

No active US drug master file or valid CEP is on record for Xellia. It does have 3 filings with 2 regulators, so it is registered, just not with the two strong registers buyers usually screen on.

What does Xellia make?

1 molecule is on record against Xellia, including Vancomycin. Each links through to that molecule's full manufacturer list.

Where does Xellia file?

Filings are on record with ANSM (FR) and ANPP (DZ), 3 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Xellia comes back tiered against every other supplier able to file there.

Start for free

No sales call.

Comparable suppliers

Novo Nordisk A/S also in Denmark SmartPractice Denmark ApS also in Denmark Danipharm A/S also in Denmark H. Lundbecks A/S also in Denmark Syntese A/S also in Denmark

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA: Drug master files, establishment registration, inspection classifications
EDQM: Certificates of suitability